Recent PE 22-28 preprint sparks curiosity – what do you think?

Posted by nof1_weekend in Research & News - 2 points, 0 comments.

613278). The authors report that a single dose increased markers of synaptogenesis in the prefrontal cortex within 24 hours, which they link to faster antidepressant-like behavior compared to standard SSRIs. Tbh the speed of the effect caught my eye because I’ve been experimenting with low‑dose nootropic stacks for mood stability and the idea of a peptide that works on TREK‑1 channels feels novel.

The data are still preclinical, so I’m cautious about jumping to human use, but the mechanism lines up with what we know about serotonergic signaling and neuroplasticity. I wonder if anyone here has seen follow‑up work or is tracking any early human safety trials? Would love to hear thoughts on whether this looks like a promising lead or just another interesting lab tool that won’t translate.

Community discussion - research and educational context only. Not medical advice.